Stericycle Inc. (NASDAQ:SRCL) had its price objective reduced by Royal Bank Of Canada from $89.00 to $77.00 in a research note issued to investors on Monday morning. They currently have an underperform rating on the stock.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Other equities analysts have also recently issued research reports about the company. Imperial Capital decreased their price target on Stericycle from $100.00 to $95.00 and set an in-line rating for the company in a report on Thursday, May 26th. Zacks Investment Research cut Stericycle from a hold rating to a sell rating in a report on Tuesday, June 28th. Jefferies Group restated a buy rating and issued a $140.00 price target on shares of Stericycle in a report on Monday, July 18th. Finally, Wellington Shields cut Stericycle from an accumulate rating to a hold rating in a report on Friday, July 29th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of Hold and an average price target of $108.95.

Stericycle (NASDAQ:SRCL) opened at 79.26 on Monday. The firm has a market capitalization of $6.74 billion, a PE ratio of 27.90 and a beta of 0.27. The stock has a 50 day moving average of $84.23 and a 200-day moving average of $102.26. Stericycle has a one year low of $76.76 and a one year high of $151.57.

Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $1.18. The firm earned $891.60 million during the quarter, compared to the consensus estimate of $910.29 million. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. The company’s revenue was up 24.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.14 EPS. On average, equities analysts predict that Stericycle will post $4.67 EPS for the current year.

In related news, Director Mark C. Miller sold 34,835 shares of the firm’s stock in a transaction on Friday, July 8th. The stock was sold at an average price of $104.52, for a total transaction of $3,640,954.20. Following the transaction, the director now directly owns 244,284 shares in the company, valued at $25,532,563.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Mark C. Miller sold 24,665 shares of the firm’s stock in a transaction on Friday, July 1st. The stock was sold at an average price of $104.55, for a total value of $2,578,725.75. Following the transaction, the director now owns 229,449 shares in the company, valued at $23,988,892.95. The disclosure for this sale can be found here. Corporate insiders own 3.30% of the company’s stock.

Institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of Stericycle by 1.8% in the second quarter. Vanguard Group Inc. now owns 7,471,494 shares of the company’s stock valued at $777,932,000 after buying an additional 135,168 shares during the period. State Street Corp raised its stake in shares of Stericycle by 0.5% in the first quarter. State Street Corp now owns 3,593,337 shares of the company’s stock valued at $453,442,000 after buying an additional 19,317 shares in the last quarter. Baillie Gifford & Co. raised its stake in shares of Stericycle by 77.2% in the second quarter. Baillie Gifford & Co. now owns 2,940,515 shares of the company’s stock valued at $306,166,000 after buying an additional 1,281,519 shares in the last quarter. Jana Partners LLC bought a new stake in shares of Stericycle during the first quarter valued at $305,997,000. Finally, BlackRock Institutional Trust Company N.A. raised its stake in shares of Stericycle by 0.8% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 2,289,722 shares of the company’s stock valued at $288,940,000 after buying an additional 19,063 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.